ONLINE DATABASE SEARCH - HIV-LS-332-MEMO
1. 47928 HIV-LS-332; EMBASE-HIV-10/3/2005
Neamine dimers targeting the HIV-1 TAR RNA
Riguet, Emmanuel, Desire, Jerome, Boden, Oliver, Ludwig, Verena, Gobel, Michael, Bailly, Christian, and Decout, Jean-Luc
Bioorganic & Medicinal Chemistry Letters 2005. 15(21): 4651-4655
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4H2FXW1-D/2/30aa16de3d12f9ebcc627988ceecb442
2. 47929 HIV-LS-332; PUBMED-HIV-10/3/2005
Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor
Ferris, RG, Hazen, RJ, Roberts, GB, St, Clair MH, Chan, JH, Romines, KR, Freeman, GA, Tidwell, JH, Schaller, LT, Cowan, JR, Short, SA, Weaver, KL, Selleseth, DW, Moniri, KR, and Boone, LR
Antimicrob Agents Chemother 2005. 49(10): 4046-51
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16189079&dopt=abstract
3. 47930 HIV-LS-332; PUBMED-HIV-10/3/2005
Evaluation of the anti-HIV activity of statins
Moncunill, G, Negredo, E, Bosch, L, Vilarrasa, J, Witvrouw, M, Llano, A, Clotet, B, and Este, JA
AIDS 2005. 19 (15): 1697-1700
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16184043&dopt=abstract
4. 47931 HIV-LS-332; PUBMED-HIV-10/3/2005
Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis
Bailly, F, Queffelec, C, Mbemba, G, Mouscadet, JF, and Cotelle, P
Bioorg Med Chem Lett 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16183277&dopt=abstract
5. 47932 HIV-LS-332; PUBMED-HIV-10/3/2005
Anti-HIV-1 constituents from Clausena excavata: Part II. carbazoles and a pyranocoumarin
Kongkathip, B, Kongkathip, N, Sunthitikawinsakul, A, Napaswat, C, and Yoosook, C
Phytother Res 2005. 19(8): 728-31
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16177980&dopt=abstract
6. 47933 HIV-LS-332; PUBMED-HIV-10/3/2005
HIV entry inhibitors: a new generation of antiretroviral drugs
Krambovitis, E, Porichis, F, and Spandidos, DA
Acta Pharmacol Sin 2005. 26(10): 1165-73
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16174430&dopt=abstract
7. 47934 HIV-LS-332; PUBMED-HIV-10/3/2005
The anti-HIV activity of ADS-J1 targets the HIV-1 gp120
Armand-Ugon, M, Clotet-Codina, I, Tintori, C, Manetti, F, Clotet, B, Botta, M, and Este, JA
Virology 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16168454&dopt=abstract
8. 47935 HIV-LS-332; PUBMED-HIV-10/3/2005
Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine
Sancho, R, de la Vega, L, Macho, A, Appendino, G, Di Marzo, V, and Munoz, E
J Immunol 2005. 175(6): 3990-3999
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16148147&dopt=abstract
9. 47936 HIV-LS-332; PUBMED-HIV-10/3/2005
Histone Deacetylase 6 Regulates Human Immunodeficiency Virus Type 1 Infection
Valenzuela-Fernandez, A, Alvarez, S, Gordon-Alonso, M, Barrero, M, Ursa, A, Cabrero, JR, Fernandez, G, Naranjo-Suarez, S, Yanez-Mo, M, Serrador, JM, Munoz-Fernandez, MA, and Sanchez-Madrid, F
Mol Biol Cell 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16148047&dopt=abstract
10. 47937 HIV-LS-332; WOS-HIV-9/25/2005
N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalam des as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
Zhao, Q, Ma, LY, Jiang, SB, Lu, H, Liu, SW, He, YX, Strick, N, Neamati, N, and Debnath, AK
VIROLOGY 2005. 339(2): 213-225, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231631900007
11. 47938 HIV-LS-332; WOS-HIV-9/25/2005
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, BP, Schafer, A, and Cullen, BR
VIROLOGY 2005. 339(2): 281-288, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231631900013
12. 47939 HIV-LS-332; EMBASE-HIV-10/3/2005
A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells
Embrey, Mark W, Wai, John S, Funk, Timothy W, Homnick, Carl F, Perlow, Debbie S, Young, Steven D, Vacca, Joseph P, Hazuda, Daria J, Felock, Peter J, and Stillmock, Kara A
Bioorganic & Medicinal Chemistry Letters 2005. 15(20): 4550-4554
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4GWC0RK-2/2/165144fa8e34d14f6a0e8403e0fd0948
13. 47940 HIV-LS-332; EMBASE-HIV-10/3/2005
Screen for underlying HIV before antiviral treatment for HBV
Wong, Ka Hing, Lee, Shui Shan, and Chan, Kenny Chi Wai
Journal of Infection 2005. 51(2): 172-173
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WJT-4G9R1DV-7/2/2bd4b8c368e250ef171be8cb6141f14c
14. 47941 HIV-LS-332; WOS-HIV-9/25/2005
Antiviral 6-amino-quinolones: Molecular basis for potency and selectivity
Richter, SN, Gatto, B, Tabarrini, O, Fravolini, A, and Palumbo, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2005. 15(19): 4247-4251, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231663400018
15. 47942 HIV-LS-332; WOS-HIV-10/2/2005
Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression
Ui, H, Asanuma, S, Chiba, H, Takahashi, A, Yamaguchi, Y, Masuma, R, Omura, S, and Tanaka, H
JOURNAL OF ANTIBIOTICS 2005. 58(8): 514-518, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231787100004
16. 47943 HIV-LS-332; WOS-HIV-10/2/2005
The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV
Sheran, M
HIV CLINICAL TRIALS 2005. 6(3): 158-168, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231815500004
17. 47944 HIV-LS-332; WOS-HIV-10/2/2005
Synthesis and biological activity of N-alkyl/aryi-N '-(4-arylthiazol-2-yl)-N '-glycosyl guanidines
Shi, HF and Cao, LH
CHINESE JOURNAL OF ORGANIC CHEMISTRY 2005. 25(9): 1066-1070, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231741300010
18. 47945 HIV-LS-332; WOS-HIV-10/2/2005
Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation
Dimitrov, AS, Louis, JM, Bewley, CA, Clore, GM, and Blumenthal, R
BIOCHEMISTRY 2005. 44(37): 12471-12479, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231942200022
19. 47946 HIV-LS-332; WOS-HIV-10/2/2005
Sensitivity of primary R5 HIV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors
Koning, FA, Koevoets, C, van, der Vorst TJK, and Schuitemaker, H
ANTIVIRAL THERAPY 2005. 10(2): 231-237, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231962300005